SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new technology and healthcare ...
SALT LAKE CITY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the substantial completion of its strategic ...
Myriad Genetics demonstrates strong year-over-year growth in testing volumes and revenue in various segments of genetic testing. The company shows good management of costs and adjusts its revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback